统一规范美容整形项目 国家医保局印发立项指南

Core Viewpoint - The beauty and cosmetic surgery market in China is rapidly expanding, with an estimated market size of nearly 300 billion yuan in 2024 [1]. Regulatory Developments - The National Healthcare Security Administration (NHSA) has issued a guideline to standardize pricing for commonly used cosmetic surgery services, addressing the prevalent issue of price discrepancies in the booming market [2][4]. - The guideline does not alter the market-based pricing management but aims to unify project names and standardize pricing behaviors among medical institutions [4]. Pricing Structure - Medical institutions can set their own prices for cosmetic surgery services, leading to significant price variations. The new guideline categorizes established procedures under unified names and standardizes abstract pricing projects [4][6]. - The guideline allows for the inclusion of popular treatments under specific categories, such as "ultrasound treatment" and "radiofrequency treatment," to enhance clarity in pricing [6]. Customization and Innovation - The guideline reflects the diverse and personalized needs of patients, allowing for detailed categorization of common procedures, such as lip enhancement [8]. - Medical institutions are permitted to establish additional charges for new technologies and equipment, subject to local healthcare department approval [8]. New Pricing Projects - The guideline introduces new pricing projects for "reduction of scarring through cosmetic suturing" and "surgical incision beautification," encouraging medical professionals to minimize scarring from the outset [9][11]. - A new charge for "revision surgery" has been established, recognizing the increased complexity and difficulty of follow-up procedures compared to initial surgeries [12][14].